# Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis

> **NCT04529226** · PHASE2 · UNKNOWN · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 75 (actual)

## Conditions studied

- Psychosis
- Intellectual Disability

## Interventions

- **DRUG:** Clozapine
- **DRUG:** haloperidol, pimozide, olanzapine, risperidone, amisulpride

## Key facts

- **NCT ID:** NCT04529226
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-26
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529226, "Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04529226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*